Statin Prescription for Primary Prevention of Cardiovascular Diseases in Patients without Hyperlipidemia: Experience from a Low-middle Income South Asian Country
In this research, the rate of statin prescription for primary prevention of ASCVD in Sri Lanka's healthcare system was found to be satisfactory, exceeding the WHO's target of 50% of eligible individuals receiving this drug therapy. However, >90% of patients at high risk of CVD were not on appropriate doses of statins. This highlights the need for improvement in individualizing treatment to administer the right dose of statin to the right patient.
Authors
- Anne Thushara Matthias (ORCID: https://orcid.org/0000-0003-0240-4845)
- Vinay Kudrigikar
- Madhuni Herath (ORCID: https://orcid.org/0000-0003-2776-2083)
- Chamila Mettananda (ORCID: https://orcid.org/0000-0002-3328-1553)
- Suranga R Manilgama
- Suyog Mehta (ORCID: https://orcid.org/0000-0001-7553-4128)
- Harsha Sathischandra
- Navaneethakrishnan Suganthan (ORCID: https://orcid.org/0000-0001-7905-6709)
- Jayanta Kumar Dey (ORCID: https://orcid.org/0000-0002-6180-5596)
- Kumudini Jayasinghe
- Sameer Rao (ORCID: https://orcid.org/0009-0006-4576-1745)
- Kandevidanalage C Janaka
- Lalith Rasnayake
- Nayanakantha Sannasuriya
Institutions
- University of Ruhuna (LK)
- University of Sri Jayewardenepura (LK)
- University of Jaffna (LK)
- Jaffna Teaching Hospital (LK)
- Colombo North Teaching Hospital (LK)
- National Hospital of Sri Lanka (LK)
Publication Details
- Journal
- Journal of the Association of Physicians of India
- Published
- 2025-05-01
- DOI
- https://doi.org/10.59556/japi.73.0994
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00